Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
As of close of business last night, Allogene Therapeutics Inc’s stock clocked out at $1.95, up 4.28% from its previous closing price of $1.87. In other words, the price has increased by $4.28 from its previous closing price. On the day, 3.17 million shares were traded. ALLO stock price reached its highest trading level at $1.96 during the session, while it also had its lowest trading level at $1.83.
Ratios:
To gain a deeper understanding of ALLO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.35 and its Current Ratio is at 9.35. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.18.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $11.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 09 ’24 when MESSEMER DEBORAH M. sold 9,136 shares for $2.18 per share. The transaction valued at 19,916 led to the insider holds 157,629 shares of the business.
Humer Franz B sold 9,221 shares of ALLO for $19,917 on Dec 05 ’24. The Director now owns 307,507 shares after completing the transaction at $2.16 per share. On Dec 09 ’24, another insider, MESSEMER DEBORAH M., who serves as the Director of the company, bought 9,136 shares for $2.18 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 408860416 and an Enterprise Value of 193046816. For the stock, the TTM Price-to-Sale (P/S) ratio is 10388.25 while its Price-to-Book (P/B) ratio in mrq is 0.88. Its current Enterprise Value per Revenue stands at 4489.461 whereas that against EBITDA is -0.757.
Stock Price History:
Over the past 52 weeks, ALLO has reached a high of $5.78, while it has fallen to a 52-week low of $1.78. The 50-Day Moving Average of the stock is -20.99%, while the 200-Day Moving Average is calculated to be -31.18%.
Shares Statistics:
It appears that ALLO traded 2.28M shares on average per day over the past three months and 2906500 shares per day over the past ten days. A total of 209.50M shares are outstanding, with a floating share count of 142.63M. Insiders hold about 31.97% of the company’s shares, while institutions hold 68.24% stake in the company. Shares short for ALLO as of 1732838400 were 31167763 with a Short Ratio of 13.67, compared to 1730332800 on 37040821. Therefore, it implies a Short% of Shares Outstanding of 31167763 and a Short% of Float of 20.899999.
